تصميم موقع كهذا باستخدام ووردبريس.كوم
ابدأ

The Russian Foreign Ministry: It is not acceptable to keep the situation in Idlib as it is

Russian Deputy Foreign Minister Oleg Siromolotov accused what he called “terrorists” of continuing to use civilians in Idlib as human shields.

Siromolotov said that “terrorists” in Idlib target the positions of the Syrian regime’s army, and this situation cannot be accepted.

“The terrorists are constantly trying to attack the Russian base in Hmeimim using drones, and of course we cannot accept this situation and our partners know this,” he added in statements to the Russian “TASS” news agency.

According to Siromolotov, Russia has contributed to “defeating international terrorism” in Syria, as he described it.

Rusya Dışişleri Bakanlığı: İdlib’deki durumun böyle kalmasını kabul edemeyiz

Rusya Dışişleri Bakan Yardımcısı Oleg Siromolotov, “teröristleri” İdlib’de sivilleri canlı kalkan olarak kullanmaya devam etmekle suçladı.

Siromolotov, İdlib’deki “teröristlerin” Suriye rejimi ordusunun mevzilerini hedef aldığını ve bu durumun kabul edilemeyeceğini söyledi.

Rus “TASS” haber ajansına verdiği demeçte, “Teröristlerin Hmeimim’deki Rus üssüne sürekli insansız hava araçlarıyla saldırmaya çalıştıklarını” sözlerine ekledi, “Elbette bu durumu kabul edemeyiz ve ortaklarımız bunu biliyor.”

Siromolotov’a göre Rusya, kendisinin tanımladığı gibi Suriye’de “uluslararası terörizmi yenmeye” katkıda bulundu.

Turkish Artillery Units are hitting the Tell Tamr region, north of Haseke, heavily.

وحدات المدفعية التركية تقصف بشدة منطقة تل تمر شمال حسكة.

Passport queue in Hama today and every dayNo hope, no work.No electricity, no diesel, no bread#massmigration

Hama’da bugün ve her gün pasaport kuyruğuUmut yok, iş yok.Elektrik yok, dizel yok, ekmek yok#kitlesel göç 今日と毎日ハマのパスポートキュー希望も仕事もありません。電気もディーゼルもパンもありません#大量移動 طابور الجوازات في مدينة حماة اليوم وكل يوملا أمل لا عمل .لاكهرباء لامازوت ولاخبز#هجرة_جماعية

The Japanese pharmaceutical company, Shionogi, has started clinical trials of a corona vaccine, which it is working to develop to be used as a booster vaccine.

And participates in the clinical trials, which began on Friday, 200 people, all of whom received two doses of the Pfizer or Moderna vaccines at least six months ago. Half of the participants will receive the Shionogi vaccine as a booster, while the other half will receive the Pfizer vaccine. The Osaka-based company will then…

نُشر بواسطة عبد العزيز شويش

هندسة عمارة www.shwiesh.com

اترك تعليقًا

إملأ الحقول أدناه بالمعلومات المناسبة أو إضغط على إحدى الأيقونات لتسجيل الدخول:

شعار ووردبريس.كوم

أنت تعلق بإستخدام حساب WordPress.com. تسجيل خروج   /  تغيير )

صورة تويتر

أنت تعلق بإستخدام حساب Twitter. تسجيل خروج   /  تغيير )

Facebook photo

أنت تعلق بإستخدام حساب Facebook. تسجيل خروج   /  تغيير )

Connecting to %s

%d مدونون معجبون بهذه: